HEM PHARMA CORP innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	EPO (European Patent Office)	14
#2	Canada	13
#3	China	5
#4	WIPO (World Intellectual Property Organization)	5
#5	South Africa	5
#6	Australia	4
#7	Mexico	3
#8	Portugal	3
#9	Ireland	2
#10	Spain	1
#11	Finland	1
#12	New Zealand	1
#13	Taiwan	1
#14	United States	1

#	Technology
#1	Medical preparations
#2	Therapeutic chemical compounds
#3	Sugars
#4	Analysing materials
#5	Measuring microorganism processes
#6	Object sterilising
#7	Climate change adaptation technologies
#8	Unspecified technologies

Publication	Filing date	Title
ES2223273A6	2003-06-24	Diagnosis of double-stranded RNA deficiency states - using mismatched double-stranded RAN, opt. administered with an interferon e.g. to treat hepatitis
AU3431593A	1993-01-05	Method of diagnosing combined cognitive/debilatory disorders
CN1088782A	1993-01-01	Use in the double stranded RNA and the method for interleukin-1
ZA9209945B	1992-12-22	Method of diagnosing combined cognitive/debilatory disorders.
CA2120027A1	1992-09-01	Method of neutralizing il-1 using dsrnas
WO9301717A1	1992-06-23	Modulation and diagnosis of cytokine dysfunctions
US5258369A	1992-06-15	Treatment of chronic cerebral dysfunction by dsRNA methodology
NZ260506A	1992-03-18	Delaying and/or reducing appearance of nucleoside analogue resistance in a virus by administering matched or mismatched dsrna prior to nucleoside analogue therapy
AU1871892A	1992-03-12	Abrogation of viral resistance to nucleoside analogues by double-stranded RNAs
EP0495919A1	1990-10-09	PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs
EP0350151A2	1989-04-26	Diagnosing and treating chronic fatigue syndrome
EP0306347A2	1988-09-05	Diagnosis of double-stranded RNA deficiency states
CA1326450C	1986-08-25	Modulation of aids virus-related events by double stranded rnas (dsrnas)